By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sarajevo TimesSarajevo TimesSarajevo Times
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Search
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: Australia Approves First Drug For Treatment Of Alzheimer’s Disease
Share
Font ResizerAa
Sarajevo TimesSarajevo Times
Font ResizerAa
  • HOME
  • POLITICS
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
  • SPORT
  • ARTS
  • W&N
Search
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Follow US
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2012 Sarajevo Times. All rights reserved.
Sarajevo Times > Blog > WORLD NEWS > Australia Approves First Drug For Treatment Of Alzheimer’s Disease
WORLD NEWS

Australia Approves First Drug For Treatment Of Alzheimer’s Disease

Published: May 23, 2025
Share
SHARE

The Australian Agency for the Regulation of Drugs and Therapies has approved the first drug for the treatment of Alzheimer’s disease.

The Therapeutic Goods Administration (TGA) approved the drug Donanemab, which has been found to slow the progression of Alzheimer’s disease by clearing protein from the brain.

The drug is intended for people with mild cognitive impairment or mild dementia caused by Alzheimer’s disease, which is the most common type of dementia. It is the leading cause of death among women in Australia and the second most common among men.

The drug is administered as an intravenous infusion every four weeks, for a maximum of 18 months.

Clinical trials have shown that it can help in the early stages of Alzheimer’s disease.

However, it cannot cure or stop cognitive decline. But it can slow the disease and allow people a better quality of life for a longer time.

The drug, which is already approved in the United Kingdom (UK) and the United States (U.S.), is not listed at this stage in the Pharmaceutical Benefits Scheme, which means it is not subsidized by the government and its use will cost between 40.000 and 80.000 dollars per year.

However, health experts warn of side effects such as brain swelling and bleeding, calling for careful monitoring.

Representatives of WB Countries discussed the new Regional Roaming Agreement
Vucic discusses Kosovo and BiH with Lavrov
Ursula von der Layen to pay an official Visit to BiH soon
Local Communities in BiH wrote to the Croatian Parliament regarding Trgovska Gora
Nigeria is the first in the world to introduce a new Meningitis Vaccine
Share This Article
Facebook Whatsapp Whatsapp Telegram Threads Bluesky Email Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Putin orders Formation of Buffer Zone on Ukraine Border
Next Article BiH Delivers First Verdict For Genocide Denial
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Stay Connected

10.2KFollowersLike
10.1KFollowersFollow
414FollowersFollow

Latest News

Interview with Bogdan Marojevic: from an unexpected Discovery to Four World Titles and an Olympic Dream
November 17, 2026
“Orka” from Mostar Wins 54 Medals in the State World Cup
November 17, 2026
From Bosnian Kings to Priceless Works of Art: Take a Peek Behind the Walls of One of the Most Famous Monasteries in BiH
November 17, 2026
Armed Forces of BiH Receive a 40-Ton Crane Worth More Than 1.4 Million BAM from the US
November 17, 2026
Average Fuel Prices in FBiH in a slight Decline
November 17, 2026
SIPA Police Officer arrested
November 17, 2026
Constituent Session of the new Convocation of the HoR of the FBiH Parliament scheduled
November 17, 2026
Ginkel congratulates the newly elected Members of BiH Presidency
November 17, 2026
BiH National Football Team Head Coach selects 23 Players for Tonight’s Match
November 17, 2026
Mayor of Konjic Visits EUFOR Headquarters at Camp Butmir
November 17, 2026
Sarajevo TimesSarajevo Times
Follow US
© 2012 Sarajevo Times. All Rights Reserved.
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?